Skip to main content

Cancer Causes & Control

Ausgabe 6/2009

Inhalt (23 Artikel)

Original Paper

Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Elizabeth A. Spencer, Timothy J. Key, Paul N. Appleby, Carla H. van Gils, Anja Olsen, Anne Tjønneland, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Marina Touillaud, Maria-José Sánchez, Sheila Bingham, Kay Tee Khaw, Nadia Slimani, Rudolf Kaaks, Elio Riboli

Original Paper

Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Reiko Suzuki, Naomi E. Allen, Paul N. Appleby, Timothy J. Key, Laure Dossus, Anne Tjønneland, Nina Føns Johnsen, Kim Overvad, Carlotta Sacerdote, Domenico Palli, Vittorio Krogh, Rosario Tumino, Sabine Rohrmann, Jakob Linseisen, Heiner Boeing, Antonia Trichopoulou, Georgios Makrygiannis, Gesthimani Misirli, H. Bas Bueno-de-Mesquita, Anne M. May, María José Tormo Díaz, Maria-José Sánchez, Aurelio Barricarte Gurrea, Laudina Rodríguez Suárez, Genevieve Buckland, Nerea Larrañaga, Sheila Bingham, Kay-Tee Khaw, Sabina Rinaldi, Nadia Slimani, Mazda Jenab, Elio Riboli, Rudolf Kaaks

Erratum

Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Reiko Suzuki, Naomi E. Allen, Paul N. Appleby, Timothy J. Key, Laure Dossus, Anne Tjønneland, Nina Føns Johnsen, Kim Overvad, Carlotta Sacerdote, Domenico Palli, Vittorio Krogh, Rosario Tumino, Sabine Rohrmann, Jakob Linseisen, Heiner Boeing, Antonia Trichopoulou, Georgios Makrygiannis, Gesthimani Misirli, H. Bas Bueno-de-Mesquita, Anne M. May, María José Tormo Díaz, Maria-José Sánchez, Aurelio Barricarte Gurrea, Laudina Rodríguez Suárez, Genevieve Buckland, Nerea Larrañaga, Sheila Bingham, Kay-Tee Khaw, Sabina Rinaldi, Nadia Slimani, Mazda Jenab, Elio Riboli, Rudolf Kaaks

Original Paper

Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada

Laura N. Anderson, Michelle Cotterchio, Steven Gallinger

Open Access Original Paper

Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case–control study

June M. Chan, Furong Wang, Elizabeth A. Holly

Original Paper

Dietary fiber and stomach cancer risk: a case–control study from Italy

Francesca Bravi, Lorenza Scotti, Cristina Bosetti, Paola Bertuccio, Eva Negri, Carlo La Vecchia

Original Paper

Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men

Meredith S. Shiels, Sabine Rohrmann, Andy Menke, Elizabeth Selvin, Carlos J. Crespo, Nader Rifai, Adrian Dobs, Manning Feinleib, Eliseo Guallar, Elizabeth A. Platz

Open Access Original Paper

MassBuilt: effectiveness of an apprenticeship site-based smoking cessation intervention for unionized building trades workers

Cassandra A. Okechukwu, Nancy Krieger, Glorian Sorensen, Yi Li, Elizabeth M. Barbeau

Open Access Original Paper

Cigarette smoking and risk of colorectal cancer among Norwegian women

Inger T. Gram, Tonje Braaten, Eiliv Lund, Loic Le Marchand, Elisabete Weiderpass

Original Paper

Relationship between cardiopulmonary mortality and cancer risk and quantitative exposure to polycyclic aromatic hydrocarbons, fluorides, and dust in two prebake aluminum smelters

Melissa C. Friesen, Geza Benke, Anthony Del Monaco, Martine Dennekamp, Lin Fritschi, Nick de Klerk, Jan L. Hoving, Ewan MacFarlane, Malcolm R. Sim

Original Paper

Dose–response meta-analysis of silica and lung cancer

Yves Lacasse, Sylvie Martin, Dominique Gagné, Lajmi Lakhal

Original Paper

Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005

Suresh H. Moolgavkar, Rafael Meza, Jay Turim

Original Paper

Maternal exposure to medical radiation and Wilms tumor in the offspring: a report from the Children’s Oncology Group

Ruchika Goel, Andrew F. Olshan, Julie A. Ross, Norman E. Breslow, Brad H. Pollock

Original Paper

Case–control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany

Peter Kaatsch, Irene Reinisch, Claudia Spix, Frank Berthold, Gritta Janka-Schaub, Andreas Mergenthaler, Jörg Michaelis, Maria Blettner

Original Paper

Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes

Lenka Goldman, Sameera Ezzat, Nadia Mokhtar, Amany Abdel-Hamid, Nathan Fowler, Iman Gouda, Soheir Abdel Latif Eissa, Mohamed Abdel-Hamid, Christopher A. Loffredo

Original Paper

County-level poverty and distant stage cancer in the United States

Robert T. Greenlee, Holly L. Howe

Original Paper

Risk of cancer among rheumatoid arthritis patients in California

Arti Parikh-Patel, Richard H. White, Mark Allen, Rosemary Cress

Original Paper

Mammography facilities are accessible, so why is utilization so low?

Lee R. Mobley, Tzy-Mey (May) Kuo, Laurel J. Clayton, W. Douglas Evans

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.